Search results
Here's What Clearside Biomedical, Inc.'s (NASDAQ:CLSD) Shareholder Ownership Structure Looks Like
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Clearside Biomedical, Inc. (NASDAQ:CLSD), then you'll have...
Analyst Bumps Up Clearside Biomedical Target Price After Encouraging Trial Data
Benzinga via Yahoo Finance· 1 year agoWednesday, Clearside Biomedical Inc (NASDAQ: CLSD) announced positive results from its OASIS Phase...
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoClearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -333.33% and 96.17%,...
Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Simply Wall St. via Yahoo Finance· 2 months agoClearside Biomedical (NASDAQ:CLSD) Full Year 2023 Results Key Financial Results Revenue: US$8.23m...
Investors in Clearside Biomedical (NASDAQ:CLSD) have unfortunately lost 84% over the last five years
Simply Wall St. via Yahoo Finance· 2 years agoSome stocks are best avoided. We really hate to see fellow investors lose their hard-earned money....
These Analysts Think Clearside Biomedical, Inc.'s (NASDAQ:CLSD) Sales Are Under Threat
Simply Wall St. via Yahoo Finance· 2 years agoThe analysts covering Clearside Biomedical, Inc. (NASDAQ:CLSD) delivered a dose of negativity to...
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoClearside Biomedical, Inc. (NASDAQ:CLSD) Q3 2023 Earnings Call Transcript November 13, 2023...
Companies Like Clearside Biomedical (NASDAQ:CLSD) Can Afford To Invest In Growth
Simply Wall St. via Yahoo Finance· 1 year agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...
GuruFocus.com via Yahoo Finance· 2 months agoLicense Revenue: Q4 revenue soared to $6.3 million, driven by a $5.0 million upfront license fee...
Clearside Biomedical Touts Encouraging Durable Data From Investigational Candidate For Vision...
Benzinga via Yahoo Finance· 1 year agoClearside Biomedical Inc (NASDAQ: CLSD) announced results from the Extension Study of its OASIS...